Pharmacological characterization of rising synthetic cannabinoids in HEK293T cells and hippocampal neurons. Our in vitro success counsel that EAM-2201 ought to be examined with regards to potential in vivo pharmacokinetic drug–drug interactions because of time-dependent inhibition of CYP2C8, CYP2C9, CYP2C19 and CYP3A4 activities and aggressive inhibition of UGT1A3 action. This https://andydyncq.collectblogs.com/76436510/what-does-eam-2201-mean